Articles by Lara Madison in JoVE
مخصص الصينية النامية الهامستر بروتين الخلية المبيض في استضافة فحوصات باستخدام التكنولوجيا الصوتية Microparticle الغشائية Matthew Dickerson1, Kristen Leong2, Kate Sheldon2, Lara Madison1 1Biomarker Division, BioScale, Inc., 2Bioprocessing Division, BioScale, Inc. يوصف تطوير المقايسات على منصة مخصصة لVIBE أكثر حساسية والنتائج واستنساخه في مصفوفات الآلي المعقدة. خرطوشة عالمي يسمح المقايسات تكييفها بسهولة للاستخدام مع فحوصات مخصصة. هذا التنوع يتيح التطور السريع والتحقق من صحة الرواية أو الإصدارات المقايسات الآلي دليل المقايسات القائمة ، والمتمثلة في هذا الفيديو.
Other articles by Lara Madison on PubMed
YfcX Enables Medium-chain-length Poly(3-hydroxyalkanoate) Formation from Fatty Acids in Recombinant Escherichia Coli FadB Strains Journal of Bacteriology. Oct, 2002 | Pubmed ID: 12270828 Expression of Escherichia coli open reading frame yfcX is shown to be required for medium-chain-length polyhydroxyalkanoate (PHA(MCL)) formation from fatty acids in an E. coli fadB mutant. The open reading frame encodes a protein, YfcX, with significant similarity to the large subunit of multifunctional beta-oxidation enzymes. E. coli fadB strains modified to contain an inactivated copy of yfcX and to express a medium-chain-length synthase are unable to form PHA(MCL)s when grown in the presence of fatty acids. Plasmid-based expression of yfcX in the FadB(-) YfcX(-) PhaC(+) strain restores polymer formation. YfcX is shown to be a multifunctional enzyme that minimally encodes hydratase and dehydrogenase activities. The gene encoding YfcX is located downstream from yfcY, a gene encoding thiolase activity. Results of insertional inactivation studies and enzyme activity analyses suggest a role for yfcX in PHA monomer unit formation in recombinant E. coli fadB mutant strains. Further studies are required to determine the natural role of YfcX in the metabolism of E. coli.
A Novel Thiolase-reductase Gene Fusion Promotes the Production of Polyhydroxybutyrate in Arabidopsis Plant Biotechnology Journal. Jul, 2005 | Pubmed ID: 17173631 The production of polyhydroxybutyrate (PHB) involves a multigene pathway consisting of thiolase, reductase and synthase genes. In order to simplify this pathway for plant-based expression, a library of thiolase and reductase gene fusions was generated by randomly ligating a short core linker DNA sequence to create in-frame fusions between the thiolase and reductase genes. The resulting fusion constructs were screened for PHB formation in Escherichia coli. This screen identified a polymer-producing candidate in which the thiolase and reductase genes were fused via a 26-amino-acid linker. This gene fusion, designated phaA-phaB, represents an active gene fusion of two homotetrameric enzymes. Expression of phaA-phaB in E. coli and Arabidopsis yielded a fusion protein observed to be the expected size by Western blotting techniques. The fusion protein exhibited thiolase and reductase enzyme activities in crude extracts of recombinant E. coli that were three-fold and nine-fold less than those of the individually expressed thiolase and reductase enzymes, respectively. When targeted to the plastid, and coexpressed with a plastid-targeted polyhydroxyalkanoate (PHA) synthase, the fusion protein enabled PHB formation in Arabidopsis, yielding roughly half the PHB formed in plants expressing individual thiolase, reductase and synthase enzymes. This work represents a first step towards simplifying the expression of the PHB biosynthetic pathway in plants.
Analysis of Two Pharmacodynamic Biomarkers Using Acoustic Micro Magnetic Particles on the ViBE Bioanalyzer Analytical Biochemistry. Mar, 2011 | Pubmed ID: 21078283 Pharmacodynamic responses to drug treatment are often used to confirm drug-on-target biological responses. Methods ranging from mass spectrometry to immunohistochemistry exist for such analyses. By far, the most extensively used methodologies employ antigen-specific antibodies for detection (at a minimum) and, in some cases, target quantitation as well. Using a novel frequency-modulating technology from BioScale called acoustic micro magnetic particle (AMMP) detection, two pathway biomarkers were chosen for pharmacodynamic analysis and compared with either AlphaScreen or LI-COR Western blot assays. For these studies, pharmacodynamic biomarkers for both proteasome and phosphoinositol 3-kinase inhibition were used. Our results show clearly that the BioScale technology is a robust and rapid method for measuring recombinant standards or endogenously derived proteins from both tissue culture and mouse xenograft tumor lysates. Moreover, the sensitivity obtained with the BioScale platform compares favorably with LI-COR Western blot and AlphaScreen technologies. Furthermore, the use of the ViBE Bioanalyzer eliminates the labor-intensive effort of Western blot analysis and is devoid of the optical and other endogenous interfering substances derived from lysates of xenograft tumors typically observed with AlphaScreen.